Idaho introduces legislation to criminalize those who administer mRNA vaccines

Immunity acquired from a Covid infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine

Researchers have developed an analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA) medicines

Maternal mRNA covid-19 vaccination during pregnancy was effective against infection or hospital admission in infants for both Delta and Omicron (study on 8809 babies in 🇨🇦)

A study in the US has found, compared to unvaccinated people, protection from the risk of dying from COVID during the six-month omicron wave for folks who had two doses of an mRNA vaccine was 42% for 40- to 59-year-olds; 27% for 60- to 79-year-olds; and 46% for people 80 and older.

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults - PubMed

mRNA vaccines induce higher long-term IgG4 response versus adenovirus vaccines

Exon architecture controls mRNA m6A suppression and gene expression

The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis